Niemann Pick type C - PIAM farmaceutici s.p.a

Niemann Pick type C is a disease of lysosomal lipid accumulation: patients with this disease are unable to metabolise lipids (e.g. cholesterol) properly, and they tend to accumulate lipids in the liver, spleen and other organs. The prevalence in the general population is about 1/100,000. The disease is characterized by autosomal recessive transmission and can […]

PIAM farmaceutici Pharma & Integrative care

Niemann-Pick disease type C as a neurovisceral disease. Schematic

The pathogenesis of Niemann–Pick type C disease: a role for autophagy?, Expert Reviews in Molecular Medicine

PIAM farmaceutici Pharma & Integrative care

What is Niemann-Pick Type C?

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson

Niemann Pick C - Dipharma SA

PIAM farmaceutici Pharma & Integrative care

Piam Iberia: Italian Pharma on the International Marketplaces - PIAM farmaceutici s.p.a

NIEMANN PICK C

Type 1 Tyrosinemia (HT-1) - PIAM farmaceutici s.p.a